Location History:
- Fairfax, CA (US) (2021 - 2024)
- Mill Valley, CA (US) (2024)
Company Filing History:
Years Active: 2021-2025
Title: Auric Anthony Sowell-Kantz: Innovator in Enzyme Engineering
Introduction
Auric Anthony Sowell-Kantz is a notable inventor based in Fairfax, CA (US). He has made significant contributions to the field of enzyme engineering, holding a total of six patents. His work focuses on developing innovative enzymes that have applications in pharmaceuticals and other industries.
Latest Patents
One of his latest patents is for engineered purine nucleoside phosphorylase variant enzymes. This invention provides engineered purine nucleoside phosphorylase (PNP) enzymes, polypeptides with PNP activity, and polynucleotides encoding these enzymes. It also includes vectors and host cells that comprise these polynucleotides and polypeptides. Methods for producing PNP enzymes are outlined, along with compositions that utilize these enzymes, particularly in the production of pharmaceutical compounds.
Another significant patent involves peroxidase activity towards 10-acetyl-3,7-dihydroxyphenoxazine. This invention offers engineered peroxidase enzymes, polypeptides with peroxidase activity, and polynucleotides encoding these enzymes. Similar to his PNP patent, it includes methods for producing peroxidase enzymes and compositions that utilize these engineered enzymes, with applications in pharmaceuticals and other compounds.
Career Highlights
Auric is currently associated with Codexis, Inc., where he continues to innovate in the field of enzyme engineering. His work has been instrumental in advancing the capabilities of enzymes for various applications, particularly in the pharmaceutical industry.
Collaborations
He collaborates with talented coworkers such as Oscar Alvizo and Da Duan, contributing to a dynamic research environment that fosters innovation and development.
Conclusion
Auric Anthony Sowell-Kantz is a prominent figure in enzyme engineering, with a strong portfolio of patents that highlight his innovative contributions to the field. His work at Codexis, Inc. continues to pave the way for advancements in pharmaceutical applications.